Northern Lipids Inc.

Press Release:
Northern Lipids Inc. (NLI) Builds Clinical Manufacturing Facility

Burnaby, BC September 10, 2007 – Northern Lipids Inc. (NLI) is pleased to announce that it has completed the renovation and build-out of its’ new Burnaby facility. Located only minutes from Vancouver airport, just off Boundary Road in South Burnaby, the building is designed to support preclinical development of pharmaceutical products, and houses a facility that is suitable for the manufacture of sterile drug products for clinical trials.

Recognizing a need to expand its operations, NLI purchased the Burnaby facility in June 2006. The building had previously been occupied by two local biotechnology companies, Response Biomedical and ID Biomedical. “Though we were able to keep much of the existing office and wet-laboratory space, the fifteen year old building needed a general face-lift and specific upgrade of selected utilities”, states Dr. Clay Flowers, NLI Director of Operations. “Renovations also included the build-out of a dedicated QC laboratory, a room designed for scale-up of our proprietary manufacturing processes, and most importantly, the addition of a clean room designed for clinical product manufacture.”

“We are very pleased to have successfully completed the renovation and expansion” says Dr. Tom Redelmeier, President and Chief Executive Officer of NLI. “It has taken a complete team effort that included not only Chernoff Thompson Architects and our General Contractor, but included important contributions from all members of the company. Since 1991, NLI has successfully grown its Contract Research Operations by listening to clients, remaining flexible and expanding our range of services to meet their growing needs. We believe that this investment in equipment and facilities will help our client’s fast-track their programs.“

About NLI

Northern Lipids Inc (NLI) is a Contract Research Organization (CRO) that provides products and services to biotechnology companies engaged in the development of pharmaceutical products. We specialize in providing services to companies that are actively developing lipid-based (liposome, emulsion, micelle) drug delivery systems. NLI has experience working with virtually all classes of pharmaceuticals, ranging from small molecules to peptides, proteins, DNA, antisense and siRNA. Our team is recognised for making a number of significant contributions to current practices and underlying concepts associated with the formulation of liposome-based pharmaceuticals.

The company offers a range of CMC (Chemistry Manufacturing Controls) related services:

• Small and large-scale LIPEX™ equipment for preparing liposomes;
• Lead prototype identification;
• Manufacturing process development & scale-up;
• Analytical method development & validation;
• Clinical trial manufacturing under cGMP
• Stability Programs

For further information, please contact Mr. Vinay Chhatre, Manager Sales & Business Development (604-638-5631) or visit our web site: www.northernlipids.com.